NCT05870813View on ClinicalTrials.gov

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer

UnknownOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

March 10, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Breast CancerHER2-negative Breast CancerHormone Receptor Positive Breast Carcinoma

Trial Locations (1)

91054

RECRUITING

Department of Gynecology and Obstetrics, Erlangen University Hospital, Erlangen

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

AGO Breast Study Group e.V.

UNKNOWN

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Institut fuer Frauengesundheit

OTHER